An open-label, 2-period pharmacokinetic study to evaluate the intra-subject variability in esomeprazole plasma levels in healthy subjects following oral administration of PN 400 [esomeprazole/naproxen] tablets.
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2010
At a glance
- Drugs Esomeprazole/naproxen (Primary)
- Indications Arthritis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
- Focus Pharmacokinetics
- Sponsors POZEN
- 29 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Feb 2008 New trial record.